Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX vs RESLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELUGOLIX vs RESLIZUMAB: Safety Overview

Metric RELUGOLIX RESLIZUMAB
Total FAERS Reports 20,660 621
Deaths Reported 958 15
Death Rate 4.6% 2.4%
Hospitalizations 1,699 121
Average Patient Age 72.4 yrs 55.9 yrs
% Female Patients 1.4% 63.2%
FDA Approval Date Dec 18, 2020 N/A
Manufacturer Sumitomo Pharma America, Inc. Teva Respiratory, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription